Product Images Tyvaso Dpi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 65 images provide visual information about the product associated with Tyvaso Dpi NDC 66302-664 by United Therapeutics Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - tyvasoDPI 01

Chemical Structure - tyvasoDPI 01

Not available.*

Figure 1 - tyvasoDPI 02

Figure 1 - tyvasoDPI 02

The text describes a comparison of the percentage of patients with a greater MWD (maximum walking distance) change between a drug called Tyvaso (with a sample size of 115) and a placebo (with a sample size of 120). The comparison is shown through a graph with a y-axis scale of <140, 120, 80, and 40, and an x-axis with increments of 20 from 0 to 100. The chart shows that the MWD change from baseline (in meters) is higher for the Tyvaso group compared to the placebo group.*

Figure 2 - tyvasoDPI 03

Figure 2 - tyvasoDPI 03

This text presents the results of a clinical trial that compared the effect of a medication called Tyvaso versus a placebo in individuals with pulmonary arterial hypertension. The trial included a total of 120 subjects, with different ages and gender, but mainly from North America. The results show several variables, such as Baseline 6MWD (distance walked in six minutes), different age quartiles, etiology, and background therapy. Additionally, the table presents the Placebo-Corrected Median Treatment Effect of Tyvaso.*

Figure 3 - tyvasoDPI 04

Figure 3 - tyvasoDPI 04

This appears to be a table showing study visit timelines and results of a medication's effects in weeks 4, 12, 15, and 16 on subjects. It also includes confidence interval percentages and median treatment effects in a placebo-controlled setting.*

Figure 4 - tyvasoDPI 05

Figure 4 - tyvasoDPI 05

This is not a readable text.*

Figure 5 - tyvasoDPI 06

Figure 5 - tyvasoDPI 06

Figure A - tyvasoDPI 07

Figure A - tyvasoDPI 07

Figure B - tyvasoDPI 08

Figure B - tyvasoDPI 08

Figure C - tyvasoDPI 09

Figure C - tyvasoDPI 09

Figure D - tyvasoDPI 10

Figure D - tyvasoDPI 10

This appears to be a list of doses, measured in mcg (micrograms), possibly for a medication or supplement. However, without additional context or information, it is not clear what these doses refer to or how they should be used.*

Figure E - tyvasoDPI 11

Figure E - tyvasoDPI 11

Figure F - tyvasoDPI 12

Figure F - tyvasoDPI 12

Figure H - tyvasoDPI 13

Figure H - tyvasoDPI 13

Image - tyvasoDPI 14

Image - tyvasoDPI 14

Image - tyvasoDPI 15

Image - tyvasoDPI 15

Figure G - tyvasoDPI 16

Figure G - tyvasoDPI 16

Image - tyvasoDPI 17

Image - tyvasoDPI 17

Image - tyvasoDPI 18

Image - tyvasoDPI 18

Image - tyvasoDPI 19

Image - tyvasoDPI 19

The text is not available as it only includes color and a single word that is difficult to determine the context.*

Image - tyvasoDPI 20

Image - tyvasoDPI 20

Figure J - tyvasoDPI 21

Figure J - tyvasoDPI 21

Figure K - tyvasoDPI 22

Figure K - tyvasoDPI 22

Figure I - tyvasoDPI 23

Figure I - tyvasoDPI 23

The text provides information about two printer cartridges, one dark blue and one light blue. Additionally, it indicates that the memory or capacity of the cartridges is 32 megabytes and 48 megabytes respectively. There is insufficient information to determine what type of cartridges they are, what brand they belong to, or what printer they are compatible with.*

Figure L - tyvasoDPI 24

Figure L - tyvasoDPI 24

Image - tyvasoDPI 25

Image - tyvasoDPI 25

Image - tyvasoDPI 26

Image - tyvasoDPI 26

Image - tyvasoDPI 27

Image - tyvasoDPI 27

Image - tyvasoDPI 28

Image - tyvasoDPI 28

Figure M - tyvasoDPI 29

Figure M - tyvasoDPI 29

Figure N - tyvasoDPI 30

Figure N - tyvasoDPI 30

Figure O - tyvasoDPI 31

Figure O - tyvasoDPI 31

Figure P - tyvasoDPI 32

Figure P - tyvasoDPI 32

Figure Q - tyvasoDPI 33

Figure Q - tyvasoDPI 33

Figure R - tyvasoDPI 34

Figure R - tyvasoDPI 34

Image - tyvasoDPI 35

Image - tyvasoDPI 35

Image - tyvasoDPI 36

Image - tyvasoDPI 36

Image - tyvasoDPI 37

Image - tyvasoDPI 37

Figure T - tyvasoDPI 38

Figure T - tyvasoDPI 38

Figure U - tyvasoDPI 39

Figure U - tyvasoDPI 39

Figure V - tyvasoDPI 40

Figure V - tyvasoDPI 40

Figure W - tyvasoDPI 41

Figure W - tyvasoDPI 41

Figure X - tyvasoDPI 42

Figure X - tyvasoDPI 42

Figure Y - tyvasoDPI 43

Figure Y - tyvasoDPI 43

Figure Z - tyvasoDPI 44

Figure Z - tyvasoDPI 44

Figure AA - tyvasoDPI 45

Figure AA - tyvasoDPI 45

Figure AB - tyvasoDPI 46

Figure AB - tyvasoDPI 46

Figure AC - tyvasoDPI 47

Figure AC - tyvasoDPI 47

Figure AD - tyvasoDPI 48

Figure AD - tyvasoDPI 48

Figure AE - tyvasoDPI 49

Figure AE - tyvasoDPI 49

Figure AF - tyvasoDPI 50

Figure AF - tyvasoDPI 50

Figure AG - tyvasoDPI 51

Figure AG - tyvasoDPI 51

Figure AI - tyvasoDPI 52

Figure AI - tyvasoDPI 52

Figure AH - tyvasoDPI 53

Figure AH - tyvasoDPI 53

PRINCIPAL DISPLAY PANEL - 16 mcg Maintenance Kit - tyvasoDPI 54

PRINCIPAL DISPLAY PANEL - 16 mcg Maintenance Kit - tyvasoDPI 54

PRINCIPAL DISPLAY PANEL - 16 mcg Institutional Kit - tyvasoDPI 55

PRINCIPAL DISPLAY PANEL - 16 mcg Institutional Kit - tyvasoDPI 55

TYVASO DPI is a medication containing treprostinil used for oral inhalation. It is available in an institutional kit, which includes multiple cartridges. It is not suitable for everyone and should only be used as prescribed by a medical professional. Some characters are not readable in the given text.*

PRINCIPAL DISPLAY PANEL - 32 mcg Maintenance Kit - tyvasoDPI 56

PRINCIPAL DISPLAY PANEL - 32 mcg Maintenance Kit - tyvasoDPI 56

PRINCIPAL DISPLAY PANEL - 32 mcg Institutional Kit - tyvasoDPI 57

PRINCIPAL DISPLAY PANEL - 32 mcg Institutional Kit - tyvasoDPI 57

This is a description for the Institutional Kit of TYVASO DPI, which is used for oral inhalation only. The kit contains 16 cartridges, each with 32 meg per cartridge. It is not clear what the active ingredient is due to errors.*

PRINCIPAL DISPLAY PANEL - 48 mcg Maintenance Kit - tyvasoDPI 58

PRINCIPAL DISPLAY PANEL - 48 mcg Maintenance Kit - tyvasoDPI 58

PRINCIPAL DISPLAY PANEL - 48 mcg Institutional Kit - tyvasoDPI 59

PRINCIPAL DISPLAY PANEL - 48 mcg Institutional Kit - tyvasoDPI 59

The text is a description of an "Institutional Kit" for oral inhalation. The kit includes 16 cartridges, each containing 48 meg per cartridge. The kit is not recommended for ventilation. The text also mentions "TYVASO DPI Sprepay | ks" (reprostni). The text provides some details related to usage and replacement of the inhalers.*

PRINCIPAL DISPLAY PANEL - 64 mcg Maintenance Kit - tyvasoDPI 60

PRINCIPAL DISPLAY PANEL - 64 mcg Maintenance Kit - tyvasoDPI 60

PRINCIPAL DISPLAY PANEL - 64 mcg Institutional Kit - tyvasoDPI 61

PRINCIPAL DISPLAY PANEL - 64 mcg Institutional Kit - tyvasoDPI 61

This appears to be a description of an Institutional Kit intended for oral inhalation only. The kit contains 16 cartridges, each containing 84 meg per cartridge inhalers of TYVASO DPI (treprostinil) recommended dosage of 820 Pressing information. The instructions on how to use the kit are also included.*

PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg Titration Kit - tyvasoDPI 62

PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg Titration Kit - tyvasoDPI 62

PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Maintenance Kit - tyvasoDPI 63

PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Maintenance Kit - tyvasoDPI 63

PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Institutional Kit - tyvasoDPI 64

PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Institutional Kit - tyvasoDPI 64

PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg 48 mcg Titration Kit - tyvasoDPI 65

PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg 48 mcg Titration Kit - tyvasoDPI 65

The text seems to be a product label for a Titration Kit called "TYVASO DPI". It may contain a drug ingredient called "treprostini" and some identification codes. However, some characters are not readable, so complete information cannot be obtained.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.